BDBM339894 5-[(2S,3R)-1-{trans-4-[1-(tert-Butoxycarbonylamino)ethyl]cyclohexanecarbonyl}-3-phenylpyrrolidine-2-carboxamide]-1-benzofuran-2-carboxylic acid::US9758480, 46

SMILES CC(N)[C@H]1CC[C@H](C(=O)N2CC[C@H](c3ccccc3)[C@H]2C(=O)Nc2ccc3oc(C(=O)O)cc3c2)CC1

InChI Key InChIKey=UDCNLRXAJYRYBT-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 339894   

TargetCoagulation factor XI(Human)
Sumitomo Dainippon Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 339894BDBM339894(US9758480, 46 | 5-[(2S,3R)-1-{trans-4-[1-(tert-But...)
Affinity DataIC50: 90nMAssay Description:0.35 μg/mL human FXIa was allowed to react with a substrate and a test compound in a 30 mmol/L HEPES buffer solution (pH 7.4) that contained 145...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2019
Entry Details
US Patent